Follow the people · Insider
Andrew Stewart Plump
Andrew Stewart Plump files insider transactions with the SEC as a president, r&d of Takeda Pharmaceutical Co (TAK). We hold 3 disclosed purchases and sales filed since 28 April 2026, 3 of them in the last 90 days.
- Files forTAK
- Disclosed buys and sells3 in all, 3 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 April 2026 — 2 September 2026President, R&D · Takeda Pharmaceutical Co (TAK)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
5 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 116,191 shares of Takeda Pharmaceutical CoSEC Form 43 September 2026American Depositary Shares · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 19,651 shares of Takeda Pharmaceutical CoSEC Form 421 August 2026American Depositary Shares · traded 19 August 2026 · filed 21 August 2026
- ▼ sold on the open market 165,393 shares of Takeda Pharmaceutical CoSEC Form 412 August 2026American Depositary Shares · traded 10 August 2026 · filed 12 August 2026
- was granted 125,390 shares of Takeda Pharmaceutical CoSEC Form 46 July 2026American Depositary Shares · traded 1 July 2026 · filed 6 July 2026
- was granted 212,470 shares of Takeda Pharmaceutical CoSEC Form 428 April 2026American Depositary Shares · traded 27 April 2026 · filed 28 April 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.